![Beneficial Effects of Intermediate Dosage of Anticoagulation Treatment on the Prognosis of Hospitalized COVID-19 Patients: The ETHRA Study. - Abstract - Europe PMC Beneficial Effects of Intermediate Dosage of Anticoagulation Treatment on the Prognosis of Hospitalized COVID-19 Patients: The ETHRA Study. - Abstract - Europe PMC](https://europepmc.org/articles/PMC7880792/bin/in_vivo-35-656-i0001.jpg)
Beneficial Effects of Intermediate Dosage of Anticoagulation Treatment on the Prognosis of Hospitalized COVID-19 Patients: The ETHRA Study. - Abstract - Europe PMC
Ioannis Karageorgos - Digital Designer and R&D Engineer - Blue Cheetah Analog Design, Inc. | LinkedIn
![Beneficial Effects of Intermediate Dosage of Anticoagulation Treatment on the Prognosis of Hospitalized COVID-19 Patients: The ETHRA Study | In Vivo Beneficial Effects of Intermediate Dosage of Anticoagulation Treatment on the Prognosis of Hospitalized COVID-19 Patients: The ETHRA Study | In Vivo](https://iv.iiarjournals.org/content/invivo/35/1/653/F1.large.jpg)
Beneficial Effects of Intermediate Dosage of Anticoagulation Treatment on the Prognosis of Hospitalized COVID-19 Patients: The ETHRA Study | In Vivo
![PDF) Quantification of Superoxide Radical in the Brain of Rats with Experimentally Induced Obstructive Jaundice PDF) Quantification of Superoxide Radical in the Brain of Rats with Experimentally Induced Obstructive Jaundice](https://i1.rgstatic.net/publication/5750892_Quantification_of_Superoxide_Radical_in_the_Brain_of_Rats_with_Experimentally_Induced_Obstructive_Jaundice/links/02bfe51050509b4222000000/largepreview.png)